The estimated Net Worth of Brian M. Stolz is at least $704 Mille dollars as of 16 August 2020. Brian Stolz owns over 1,595 units of BridgeBio Pharma Inc stock worth over $704,424 and over the last 8 years Brian sold BBIO stock worth over $0.
Brian has made over 2 trades of the BridgeBio Pharma Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Brian exercised 1,595 units of BBIO stock worth $44,644 on 16 August 2020.
The largest trade Brian's ever made was exercising 134,845 units of BridgeBio Pharma Inc stock on 13 August 2019 worth over $5,476,055. On average, Brian trades about 12,404 units every 34 days since 2016. As of 16 August 2020 Brian still owns at least 25,167 units of BridgeBio Pharma Inc stock.
You can see the complete history of Brian Stolz stock trades at the bottom of the page.
Brian's mailing address filed with the SEC is C/O BRIDGEBIO PHARMA, INC., 421 KIPLING STREET, PALO ALTO, CA, 94301.
Over the last 5 years, insiders at BridgeBio Pharma Inc have traded over $409,396,563 worth of BridgeBio Pharma Inc stock and bought 12,280,644 units worth $209,241,115 . The most active insiders traders include Global Investors Lp Viking ..., Andrew Lo e Genetic Disorder L.P.Kkr Ge.... On average, BridgeBio Pharma Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,173,197. The most recent stock trade was executed by Neil Kumar on 16 August 2024, trading 55,537 units of BBIO stock currently worth $1,554,481.
we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.
BridgeBio Pharma Inc executives and other stock owners filed with the SEC include: